Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the veterans health administration

American Journal on Addictions

Volumn 17, Issue 6, 2008, Pages 459-462

  Gordon, Adam J ^a,b   Liberto, Joseph ^a,c   Granda, Stephanie ^d   Salmon Cox, Sara ^a   Andrée, Tykia ^a   McNicholas, Laura ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE;

ACCREDITATION; ARTICLE; CERTIFICATION; FOLLOW UP; GOVERNMENT; HUMAN; NARCOTIC DEPENDENCE; OUTCOME ASSESSMENT; PHYSICIAN; PRESCRIPTION; TRAINING;

BUPRENORPHINE; CERTIFICATION; EDUCATION; FOLLOW-UP STUDIES; HEALTH OCCUPATIONS; HUMANS; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 57049119105     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490802408613     Document Type: Article

References (13)

1. Gordon AJ, Trafton JA, Saxon AJ, et al. Implementation of buprenorphine in the Veterans Health Administration: Results of the first three years. Drug Alcohol Depend. 2007;90:292-296.
2. Goodman F, Gordon A, Kivlahan D, et al. Criteria for use of buprenophine/naloxone and Buprenorphine sublingual tablets. Available at: http://www.pbm.va.gov/criteria/BuprenorphineCriteriaForUse.pdf. Accessed October 1, 2007.
3. Drug Addiction Treatment Act of 2000.42 USC§3502a.
4. Stanton A, McLeod C, Luckey B, et al. SAMHSA/CSAT evaluation of the buprenorphine waiver program. Expanding treatment of opioid dependence: Initial physician and patient experiences with the adoption of buprenorphine. Available at: http://buprenorphine.samhsa.gov/ASAM_06_Final_Results.pdf. Accessed December 5, 2006.
5. Kissin W, McLeod C, Sonnefeld J, et al. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence. J Addict Dis. 2006;25:91-103.
6. Gunderson EW, Fiellin DA, Levin FR, et al. Evaluation of a combined online and in person training in the use of buprenorphine. Subst Abuse. 2006;27:39-45.
7. Kleber H. Differential patterns of buprenorphine use in the U.S. presentation at the 2008 American Psychiatric Association. May 5, 2008, Washington, D.C.
8. Renner JA. Presentation at the 2008 Buprenorphine in the Treatment of Opioid Addiction: Expanding Access-Enhancing Quality (2008 Buprenorphine Summit): Education status report: Successes & challenges. February 21, 2008, Washington D.C.
9. Wong JG, Holmboe ES, Jara GB, et al. Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependence. Subst Abuse. 2005;25:35-40.
10. Kirkpatrick DL, Kirkpatrick JD. Transferring Learning to Behavior. San Francisco, Calif.: Berrett-Koehler Publishers, Inc, 2005.
11. Phillips JJ, Stone RD. How to Measure Training Results. New York, NY: McGraw-Hill, 2002.
12. McNicholas LF, Gordon AJ, Kane V, Lowe J, Singh G. Buprenorphine in the treatment of opiate dependence: A network-wide initiative. Poster presentation at the 2005 Best Practices in VHA Mental Healthcare Systems. Mesa, Ariz., October 2005.
13. Fiellin DA, O'Connor PG. Clinical practice. Office-based treatment of opioid-dependent patients. N Engl J Med. 2002;347:817-823.